Health Care/Hospital

Breakthrough Therapy Designation (BTD) for BioCity's SC0062, a selective endothelin type A (ETA) antagonist, granted by National Medical Products Administration for IgA nephropathy (IgAN) with proteinuria

SHANGHAI, Sept. 26, 2024 /PRNewswire/ -- BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 has been granted the Breakthrough Therapy Designation (BTD) by National Medical Products Administration (NMPA) for the treatment of IgA nephropathy (IgAN...

2024-09-26 15:10 1392

Innovent Announces NMPA Acceptance of NDA for Picankibart (Anti-IL-23p19 Antibody) for Treating Moderate to Severe Plaque Psoriasis

SAN FRANCISCO and SUZHOU, China, Sept. 26, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli...

2024-09-26 12:15 1862

ISUOG 2024 | Redefining Women's Health with SonoScape's New Fenix 80 Series

BUDAPEST, Hungary, Sept. 26, 2024 /PRNewswire/ -- SonoScape  (300633.SZ), a prominent innovator in medical technology specializing in ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery (MIS), and cardiovascular intervention solu...

2024-09-26 12:02 1382

Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study Findings

PERTH, Australia, Sept. 26, 2024 /PRNewswire/ -- A groundbreaking study published inClinical Obesity reveals that providing personalised energy expenditure data significantly improves weight loss outcomes in individuals with obesity1 . Condu...

2024-09-26 08:11 1704

Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis

SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewedstudy validating its innovative method for measuring central aortic pressure...

2024-09-26 07:15 1526

Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management

SEOUL, South Korea, Sept. 25, 2024 /PRNewswire/ -- Mediwhale , the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for...

2024-09-26 02:00 1845

Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care

The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules SALT LAKE CITY and NASHVILLE, Tenn., Sept. 25, 2024 /PRNewswir...

2024-09-25 22:02 2084

Shin-Etsu SE Tylose and LBB Specialties Announce Distribution Partnership for Cellulose Pharma Excipients in North and Central America

NORWALK, Conn., Sept. 25, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution inNorth America, announces a new partnership with SE TyloseUSA for cellulose excipients in the Pharma Excipients and Nutra Ingredients markets. EffectiveNovember 1, 2...

2024-09-25 22:00 1453

The World First Liquid Formulation of Recombinant Botulinum Toxin Type A Has Obtained IND Approval by the FDA

CHONGQING, China, Sept. 25, 2024 /PRNewswire/ -- MingMed Biotechnology, an innovative company focused on the in-house discovery and development of novel drugs, recently announced that its partially owned subsidiary, Claruvis Pharmaceutical Co., has received approval from the U.S. Food and Drug A...

2024-09-25 21:18 1772

Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC Regulatory Harmonization Steering Committee

PHILADELPHIA, Sept. 25, 2024 /PRNewswire/ -- Rx-360® is pleased to announce that it has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global Medical Product Supply Chain Integrity Priority Work Area R...

2024-09-25 21:09 1560

Bloomage's Pioneering Pilot-Scale Testing Platform Now Fully Operational, Ushering in New Era of Open Innovation

PARSIPPANY, N.J., Sept. 25, 2024 /PRNewswire/ -- Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, has announced the completion of its new pilot-scale testing platform. With the pharmaceutical-grade pilot testing wing now fully operational, this ...

2024-09-25 21:00 1146

Flat Medical Strengthens Market Leadership with Acquisition of InjeQ Assets, Including FDA-Designated Breakthrough Device IQ-Tip®

TAIPEI, Sept. 25, 2024 /PRNewswire/ -- Flat Medical, a leading innovator in medical technology, today announced its acquisition of key assets from InjeQ, including the FDA-designated breakthrough device, IQ-Tip®. This strategic move bolsters Flat Medical's leadership position in the medical devic...

2024-09-25 20:00 1487

SI GROUP ANNOUNCES PLANS TO CLOSE MANUFACTURING SITE IN SINGAPORE

Company plans to cease manufacturing operations in second half of 2025 due to declining market conditions THE WOODLANDS, Texas, Sept. 25, 2024 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermedi...

2024-09-25 20:00 1852

CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean - Decentralised Approach Serves the Needs of the Caribbean Community

HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ -- CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed's Xceler8 Platform across theCaribbean. Implementing this cutting-edge technology in the region marks a major advancement in the field ofCaribbean ge...

2024-09-25 19:00 1572

Samsung Biologics launches development platforms for enhanced therapeutic efficacy

* Samsung Biologics showcases new innovative development platforms – S-AfuCHO TM and S-OptiChargeTM – at BioProcess International 2024 * New technology platforms to proactively address evolving industry trends and enable high-quality development INCHEON, South Korea, Sept. 25, 2024 /PRNewswire...

2024-09-25 19:00 1300

New Research from the International Coaching Federation Highlights Trends in Workplace Burnout

 - Demand for mental well-being support becoming widespread - LEXINGTON, Ky., Sept. 25, 2024 /PRNewswire/ -- New research, released today by the International Coaching Federation (ICF), indicates growing workplace demand for mental well-being support. With mental well health concerns including b...

2024-09-25 17:00 1435

GSK's Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia

* Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV * Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy observed in adults with co-morbidities vii KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire...

2024-09-25 16:45 1738

FONDAZIONE PRADA PRESENTS "PRESERVING THE BRAIN: A CALL TO ACTION" IN MILAN

MILAN, Sept. 25, 2024 /PRNewswire/ -- The new edition of "Preserving the Brain," part of Fondazione Prada's "Human Brains" project dedicated to neurosciences since 2018, will focus on the prevention of neurodegenerative diseases. Organized in partnership with fifteen renowned neuroscience instit...

2024-09-25 16:00 1289

Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies

* Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach. SHANGHAI, Sept. 25, 2024 /PRNewswire/ -- Belief BioMed Inc. (BBM), a biotech company focusing on innovative gene therapies, today announce...

2024-09-25 14:58 1454

Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024

* Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports interchangeability between adalimumab and adalimumab-fkjp * Biosimilarity between Bmab 1200 and reference biologic-Ustekinumab in pivotal Phase 3 trial in patients with moder...

2024-09-25 13:21 1283
1 ... 28293031323334 ... 847